| Literature DB >> 27112720 |
Abstract
Occupational exposure to elemental mercury vapor usually occurs through inhalation during its utilizations. This leads to a variety of adverse health effects. In some Islamic cities, this type of poisoning may occur during gilding of shrines using elemental mercury with gold. Herein, we report on three male patients aged 20-53 years, who were diagnosed with occupational metallic mercury poisoning due to gilding of a shrine. All patients presented with neuro-psychiatric disorders such as anxiety, loss of memory and concentration, and sleep disorders with high urinary mercury concentrations of 326-760 μg/L upon referring, 3-10 days after cessation of elemental mercury exposure. Following chelating therapy, the patients recovered clinically and their mercury concentrations declined to non-toxic level (<25 μg/L). Health, environmental and labor authorities, as well as the gilders should be aware of the toxicity risk of exposure to metalic mercury during gilding in closed environments and act accordingly.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27112720 PMCID: PMC6816512 DOI: 10.15171/ijoem.2016.776
Source DB: PubMed Journal: Int J Occup Environ Med ISSN: 2008-6520
|
| ||||||
| 67/Male | Ingestion, inhalation (suicidal attempt) | Severe pneumonitis, ARF*, anuria | Blood: 1577 | Hemodialysis, No | Japan | |
| 46/Female | Manometer used in the arterial line | Severe pain, ischemia, erythematous lesions, cyanosis of the left hand | Blood: 192.9 | Nitroglycerin patches, codeine, acetaminophen, and penicillamine | Brazil | |
| 40/Male | Self-injection of elemental mercury | Schizophrenia and inflammatory soft tissue lesions | 24-h urine: 6 | Broad-spectrum antibiotics, surgical debridement of necrotic tissue | USA | |
| 21/Male | Self-injection of elemental mercury by breaking | Granuloma in the | Serum: 11 | Surgical removal of mercury | Georgia | |
| 22/Male | Repeated self-administration of metallic mercury injection | Arthromyalgias, fever, weakness, chest pain (multiple punctuates metallic densities in radiographs) | Blood: 370 | Mercury micro-emboli management | Spain | |
| 36/Male | Chronic mercury vapor exposure and possible iv injection | Rash, sore throat, fever, chills, cough and diarrhea | N/A | Chelating therapy with DMSA† and DMPS‡ | USA | |
| 36/Female | Heating the liquid form of mercury | Abdominal pain, | Not tested on admission—blood: 300 at discharge | Symptomatic chelation treatment with N-acetyl cysteine (NAC) | Turkey | |
| *ARF: Acute renal failure; †DMSA: Dimercaptosuccinic acid; ‡DMPS: Dimercapto-propane-sulfonic acid; N/A: Not available | ||||||